Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1. Pregnant women <br/ >2. Breastfeeding women <br/ >3. Known hypersensitivity to blood products <br/ >4. Receipt of pooled immunoglobulin in last 30 days <br/ >5. Critically ill patients: <br/ >a. P/F ratio <200 (moderate - severe ARDS) <br/ >b. Shock <br/ >6. Participating in any other clinical trial <br/ >7. Clinical status precluding infusion of blood products <br/ >	1. Pregnant women <br/ >2. Breastfeeding women <br/ >3. Known hypersensitivity to blood products <br/ >4. Receipt of pooled immunoglobulin in last 30 days <br/ >5. Critically ill patients: <br/ >a. P/F ratio <200 (moderate - severe ARDS) <br/ >b. Shock <br/ >6. Participating in any other clinical trial <br/ >7. Clinical status precluding infusion of blood products <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	1. Pregnant women <br/ >2. Breastfeeding women <br/ >3. Known hypersensitivity to blood products <br/ >4. Receipt of pooled immunoglobulin in last 30 days <br/ >5. Critically ill patients: <br/ >a. P/F ratio <200 (moderate - severe ARDS) <br/ >b. Shock <br/ >6. Participating in any other clinical trial <br/ >7. Clinical status precluding infusion of blood products <br/ >	1. Pregnant women <br/ >2. Breastfeeding women <br/ >3. Known hypersensitivity to blood products <br/ >4. Receipt of pooled immunoglobulin in last 30 days <br/ >5. Critically ill patients: <br/ >a. P/F ratio <200 (moderate - severe ARDS) <br/ >b. Shock <br/ >6. Participating in any other clinical trial <br/ >7. Clinical status precluding infusion of blood products <br/ >